Utah Medical Products, Inc. UTMD
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- +26.07%
- 1 year
- +21.43%
- Open
- 68.83
- Prev close
- 68.08
- Mkt cap
- 200.87M
- Vol
- 38.99K
- Avg vol
- 35.54K
- EPS
- 3.34
- P/E
- 21.12
- Div yield
- 2.00%
More statistics
- Low
- 68.71
- High
- 71.05
- Forward P/E
- 0.00
- Beta
- 0.08
- Short ratio
- 2.77
- Inst. own
- 73.66%
- Dividend
- 1.22
- Ex-div date
- Dec 15, 2024
- 50-d avg
- 64.91
- 200-d avg
- 67.23
- 1y target
- 0.00
6M chart
Events in this range
- Jun 17, 2026Dividend: 0.31
- Sep 17, 2026Dividend: 0.31
Signals (28)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 28, 2026 | 5 days ago |
| RSI: Oversold | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
Key statistics
- Market cap
- 207.33M
- Enterprise value
- 121.79M
- Trailing P/E
- 14.28
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 4.70
- Price / book
- 1.69
- EPS (TTM)
- 4.28
- Beta
- 0.08
- Dividend yield
- 2.00%
- Payout ratio
- 28.04%
- Profit margin
- 34.62%
- Revenue (TTM)
- 44.08M
- Revenue growth
- -20.00%
- Free cash flow
- 0
- Total cash
- 88.45M
- Total debt
- 299.00K
- Return on equity
- 12.31%
- Shares outstanding
- 3.39M
- Short % of float
- 2.33%
- 50-day average
- 64.91
- 200-day average
- 67.23
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 29, 2024 | Sep 1, 2024 | 0.00 | 1.02 | — | — |
| Jul 25, 2024 | Jun 1, 2024 | 0.00 | 0.98 | — | — |
| Apr 25, 2024 | Mar 1, 2024 | 0.00 | 1.09 | — | — |
| Jan 30, 2024 | Dec 1, 2023 | 0.00 | 1.18 | — | — |
| Oct 26, 2023 | Sep 1, 2023 | 0.00 | 1.08 | — | — |
| Jul 25, 2023 | Jun 1, 2023 | 0.00 | 1.15 | — | — |
About Utah Medical Products, Inc.
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- utahmed.com
News
- UTMD's Q3 Earnings Rise Y/Y on Lower Costs, Orion Acquisition
- Utah Medical Products Q3 EPS $0.88 Up From $0.82 YoY, Sales $8.621M Down From $9.812M YoY
- UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
- UTMD Trades at a Premium to the Industry: How to Play the Stock?
- Utah Medical Products, Inc. Extends Tender Offer
- Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
- Utah Medical Products, Inc. Commences Tender Offer
- UTMD Announces Self-Tender for 20% of Its Shares
- BlackRock Inc. Invests $14.05 Million in Utah Medical Products, Inc. $UTMD
- Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
Your note
Sign in to keep a note on UTMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| KOOPMAN BRIAN L. | Officer | Stock Gift | Jul 17, 2024 | 882 |
| PAYNE BARBARA A | Director | Stock Gift | Feb 7, 2023 | 4,838 |
| RICHINS PAUL O | Director | Stock Gift | May 16, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 7.93% | 268,823 | 16.43M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 6.80% | 230,614 | 14.10M | Sep 29, 2024 |
| Vanguard Group Inc | 5.34% | 181,169 | 11.07M | Sep 29, 2024 |
| Blackrock Inc. | 5.31% | 180,095 | 11.01M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 5.17% | 175,504 | 10.73M | Sep 29, 2024 |
| Brandes Investment Partners L.P. | 4.08% | 138,365 | 8.46M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Low-Priced Stock Fund | 3.56% | 120,637 | 7.37M | Aug 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.19% | 108,096 | 6.61M | Sep 29, 2024 |
| Fidelity Small Cap Discovery Fund | 1.70% | 57,500 | 3.51M | Aug 30, 2024 |
| iShares Russell 2000 ETF | 1.68% | 56,965 | 3.48M | Oct 30, 2024 |
| JP Morgan Small Cap Blend Fund | 1.65% | 56,125 | 3.43M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.44% | 48,796 | 2.98M | Sep 29, 2024 |